GTC Biotherapeutics (fka GTCB)

[anotherbiotechguy]

People believe all sorts of things, but if you accept Dew's assertion that this is all normal market activity, then I would suggest Rustyboy's post 4141. The future still looks reasonably bright depending on your glasses, but the market wants proof. Not proof of technology. Not proof of authorization hurdles. They want proof, not promise, of profit and margin. Once that happens, then promise will be sufficient for future products. My assumption is this will require something bigger than the HD market.